HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teske Schoffelen Selected Research

Q Fever (Fever, Q)

1/2022Differences in local immune cell landscape between Q fever and atherosclerotic abdominal aortic aneurysms identified by multiplex immunohistochemistry.
10/2018Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.
7/2018Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome.
1/2017CXCL9, a promising biomarker in the diagnosis of chronic Q fever.
10/2016A fatal case of disseminated chronic Q fever: a case report and brief review of the literature.
4/2016Altered interferon-γ response in patients with Q-fever fatigue syndrome.
1/2016Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.
9/2015Genetic Variation in Pattern Recognition Receptors and Adaptor Proteins Associated With Development of Chronic Q Fever.
4/2015Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.
1/2015Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teske Schoffelen Research Topics

Disease

15Q Fever (Fever, Q)
01/2022 - 06/2013
4Infections
11/2016 - 01/2014
3Endocarditis
10/2016 - 06/2014
2Fatigue
07/2018 - 04/2016
2Aneurysm (Aneurysms)
10/2016 - 01/2015
2Aortic Aneurysm (Aneurysm, Aortic)
10/2016 - 11/2014
1Persistent Infection
04/2015
1Rheumatoid Arthritis
06/2014

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
10/2018 - 01/2014
3InterferonsIBA
07/2018 - 06/2013
3Interleukin-2 (IL2)IBA
07/2018 - 01/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 06/2014
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2015
2EnzymesIBA
10/2016 - 01/2014
2AntigensIBA
04/2016 - 04/2015
2Interferon-gamma (Interferon, gamma)IBA
01/2015 - 01/2014
2VaccinesIBA
11/2014 - 12/2013
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
10/2018
1Interleukin-10 (Interleukin 10)IBA
10/2018
1ChemokinesIBA
01/2017
1ImmunosorbentsIBA
10/2016
1Complement System Proteins (Complement)IBA
10/2016
1InterleukinsIBA
04/2016
1Proteins (Proteins, Gene)FDA Link
09/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2015
1IntegrinsIBA
09/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2015
1NucleotidesIBA
09/2015
1Pattern Recognition ReceptorsIBA
09/2015
1AerosolsIBA
04/2015
1Immunologic Factors (Immunomodulators)IBA
04/2015
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
1Immunoglobulin G (IgG)IBA
06/2014
1Rituximab (Mabthera)FDA Link
06/2014

Therapy/Procedure

3Prostheses and Implants (Prosthesis)
10/2016 - 11/2014
1Blood Vessel Prosthesis
10/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2014
1Immunotherapy
06/2014